Clinical Trial Detail

NCT ID NCT03056833
Title Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Carboplatin + Paclitaxel + Ribociclib

Age Groups: adult senior

No variant requirements are available.